Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 16, Issue 6, 2006, Pages 395-404

  Ristić Medić, Danijela ^a   Ristić, Vanja ^a   Arsić, Aleksandra ^a   Poštić, Marija ^a   Ristić, Gordana ^a   Blaženčić Mladenović, Vera ^a   Tepšić, Jasna ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Diabetes mellitus; Fatty acid; Lecithin; Serum lipids; Soybean

Indexed keywords

GLYCINE MAX;

EID: 33748083661     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.06.008     Document Type: Article

References (63)

1. Estman R.C., and Keen H. The impact of cardiovascular disease on people with diabetes: the potential for prevention. Lancet 350 Suppl. 1 (1997) S129-S132
2. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-341
3. Austin M.A., and Edwards K.L. Small dense low density lipoproteins, the insulin resistance syndrome and non-insulin-dependent diabetes. Curr Opin Lipidol 7 (1996) 167-171
4. Grundy S.M. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 81 (1998) 18B-25B
5. Haffner S.M. Management of dyslipidemia in adults with diabetes. Diabetes Care 21 (1998) 160-178
6. Vinik A.I., O′Brian J.T., Georges I.P., Leichter S.B., and Janin Y. Management of hyperlipidemia in diabetes. Compr Ther 21 (1995) 602-609
7. Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: the World Health Organization Multinational Study of vascular disease in diabetics. Diabetologia 28 (1985) 615-640
8. Deedwania P.C., Hunnighake D.B., and Bayas H. Effects of lipid-altering treatment in diabetes mellitus and metabolic syndrome. Am J Cardiol 93 (2004) 18C-26C
9. Carroll K.K., and Kurowska E.M. Soy consumption and cholesterol reduction: review of animal and human studies. J Nutr 125 (1995) 594S-597S
10. Huang Y.S., Koba K., Horrobin D.F., and Sugano M. Interrelationship between dietary protein, cholesterol and n-6 polyunsaturated fatty acid metabolism. Prog Lipid Res 32 (1993) 123-137
11. Wong W.W., O'Brian Smith E., Stuff J.E., Hachey D.L., Heird W.C., and Pownell H.J. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr 68 Suppl. (1998) 1385S-1389S
12. Tonstard S., Smerud K., and Hoie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 76 (2002) 78-84
13. Potter S.M. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125 (1995) 606S-661S
14. Anderson J.W., Johnsstone B.M., and Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl Med 333 (1995) 276-282
15. Baum J.A., Teng H., Erdman J.W., Weigel R.M., Klein B.P., Persky V.W., et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density lipoprotein receptor messenger RNA in hypercholesterolaemic, postmenopausal women. Am J Clin Nutr 68 (1998) 545-551
16. Sirtori C.R., Lovati M.R., Manzoni C., Giannazza E., Bondioli A., Steals B., et al. Reduction of serum cholesterol by soy protein: clinical experience and potential molecular mechanisms. Nutr Metab Cardiovasc Dis 8 (1992) 887-894
17. Jimenez M.A., Scarino M.L., Vignolini F., and Mengheri E. Evidence that polyunsaturated lecithin induces a reduction in plasma cholesterol level and favorable changes in lipoprotein composition in hypercholesterolemic rats. J Nutr 120 (1990) 659-667
18. Iwata T., Hoshi S., Takehisa F., Tsutsumi K., Furukawa Y., and Kimura S.J. The effect of dietary safflower phospholipid on plasma and liver lipids in rats fed a hypercholesterolemic diet. J Nutr Sci Vitaminol 38 (1992) 471-479
19. Polichetti E., Diaconesku N., De La Porte P.L., Malli L., Portugal H., Pauli A.M., et al. Cholesterol-lowering effect of soybean lecithin in normolipidaemic rats by stimulation of biliary lipid secretion. Br J Nutr 75 3 (1996) 471-478
20. Tompkins R.K., and Parkin L.G. Effects of long-term ingestion of soy phospholipids on serum lipids in human. Am J Surg 140 3 (1980) 360-364
21. Sirtori C.R., Zucchi-Dentone C., Sirtori M., Gatti E., Descovich G.S., Gaddi A., et al. Cholesterol-lowering and HDL-raising properties of lecithinated soy proteins in type II hyperlipidemic patients. Ann Nutr Metab 29 6 (1985) 348-357
22. Kurowska E.M., Jordan J., Spence J.D., et al. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects. Clin Invest Med 20 3 (1997) 162-170
23. Cobb M., Turkki P., Linscheer W., and Raheja K. Lecithin supplementation in healthy volunteers. Effect on cholesterol esterification and plasma, and bile lipids. Nutr Metab 24 (1980) 228-237
24. Greten H., Raetzer H., Stiehl A., and Schettler G. The effect of polyunsaturated phosphatidylcholine on plasma lipids and fecal sterol excretion. Atherosclerosis 36 (1980) 81-88
25. Ide T., Hirabayashi S., Kano S., and Sugano M. Soybean phospholipid-dependent reduction in triacylglycerol concentration and synthesis in the liver of fasted-reefed rats. Biochim Biophys Acta 1124 (1992) 163-170
26. Ide T., and Murata M. Depressions by dietary phospholipids of soybean and egg yolk origins of hepatic triacylglycerol and fatty acid synthesis in fasted-refed rats. Ann Nutr Metab 38 (1994) 340-348
27. Jerkins D.J.A., Kendall C.W.C., Vidgen E., Mehling C.C., Parker T., Seyler H., et al. The effects on serum lipids and oxidized low-density lipoprotein of supplementing self-selected low-fat diet with soluble fiber, soy, and vegetable protein foods. Metabolism 49 (2000) 67-72
28. Hermansen K., Sondergraad M., Hoie L., Carstensen M., and Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes care 24 2 (2001) 228-233
29. Bhathena S.J., and Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76 (2002) 1191-1201
30. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 24 (2003) S5-S20
31. Lopes-Virela M.F., Stone P., Ellis S., and Colwell J.A. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23 (1977) 882-886
32. Friedewald W.T., Levy R.I., and Friedrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 18 (1972) 449-502
33. Matusik E.J., Reeves V.B., and Flanagan V.P. Determination of fatty acid methyl esters. Anal Chim Acta 166 (1984) 179-188
34. Harth S., Dreyfus H., Urban P.F., and Mandel P. Direct thin-layer chromatography of gangliosides of total lipid extracts. Anal Biochem 86 (1978) 543-551
35. Ristić Medić D., Ristić V., Tepšić V., Ranić M., Ristić G., Vrbaški S., et al. Effect of soybean leci-vita product on serum lipids and fatty acids composition in patients with elevated serum cholesterol and triglyceride levels. Nutr Res 23 (2003) 465-477
36. Ristić V., Vrbaški S.R., Lalić Z., and Mirić M. The effect of ethanol and diazepam on the fatty acid composition of plasma and liver phospholipids in the rat. Biol Pharm Bull 18 (1995) 842-845
37. Fujikawa T. Utilisation of lecithin and practical functions for dietary use. Yukagaku 40 (1991) 951-958
38. Ishinaga M., Sugiyama S., and Mochizuki T. Daily intakes of fatty acids, sterols and phospholipids by Japanese women and serum cholesterol. J Nutr Sci Vitaminol 40 (1994) 557-567
39. Summary of second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of height blood cholesterol in adults. JAMA 269 (1993) 3015-3023
40. Austin M.A., Hokanson J.E., and Edwards K.L. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 81 (1998) 7B-12B
41. Taixeira S., Potter S., Weigel R., Hannum S., Erdman J., and Hasler C. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 71 (2000) 1077-1084
42. Gensini G.F., Comeglio M., and Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J 19 (1998) S53-S61
43. Wilson T.A., Meservey C.M., and Nicolosi R.J. Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate. Atherosclerosis 140 1 (1998) 147-153
44. O'Brien S.F., Watts G.F., Playford D.A., Burke V., O'Neal D.N., and Best J.D. Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes. Diabet Med 14 (1997) 974-978
45. Bruckner G. Fatty acid and cardiovascular diseases. In: Chow C.K. (Ed). Fatty acids in foods and their health implications (2000), Food Science and Technology, New York 843-863
46. Dougherty R.M., Galli G., Ferro-Luzzi A., and Iacono J.M. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: study of normal subjects from Italy, Finland and USA. Am J Clin Nutr 45 (1987) 443-455
47. Okita M., Yoshida S., Yamoto J., Suzuki K., Kaneyuki T., Kubota M., et al. N-3 and n-6 fatty acid intake and serum phospholipid fatty acid composition in middle-aged women living in rural and urban areas in Okayama prefecture. J Nutr Sci Vitaminol 41 (1995) 313-323
48. Wang L., Folsom A.R., Zheng Z.J., Pankow J.S., and Eckfeldt J.H. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78 (2003) 91-98
49. Vessby B., Tengblad S., and Lithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37 (1994) 1044-1050
50. Folsom A.R., Ma J., McGovern P.G., and Eckfeldt J.H. Relation between plasma phospholipid saturated fatty acids and hyperinsulinemia. Metabolism 45 (1996) 223-228
51. Horrobin D.F. The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 31 (1988) 181-197
52. Bailey C.J., Williams G., and Pickup J.C. New drug in the management of diabetes mellitus and its complications. In: Pickup J.C., Williams G., et al. (Eds). Textbook of diabetes vol. 2 (1997), Blackwell, Oxford-London-Edinbourg 84.1-84.30
53. Pelikanova T., Kohout M., Válek J., Base J., and Stefka Z. Fatty acid composition of serum lipids and erythrocyte membranes in type 2 (non-insulin-dependent) diabetic men. Metabolism 40 (1991) 175-180
54. Bassi A., Avogaro A., Crepaldi C., Pavan P., Zambon S., Marin R., et al. Short-term diabetic ketosis alters n-6 polyunsaturated fatty acid content in plasma phospholipids. J Clin Endocrinol Metab 81 (1996) 1650-1653
55. Bohov P., Balaz V., Segokova E., and Klimes I. The effect of hyperlipidemia on serum fatty acid composition in type 2 diabetics. Ann N Y Acad Sci 827 (1997) 561-567
56. Nakamura N., Hamazaki T., Jokaji H., Minami S., and Kobayashi M. Effect of HMG-CoA reductase inhibitors on plasma polyunsaturated fatty acid concentrations in patients with hyperlipidemia. Int J Clin Lab Res 28 (1998) 192-195
57. Jones D.B., Carter R.D., Haitas B., and Mann J.I. Low phospholipid arachidonic acid values in diabetic platelets. BMJ 286 (1983) 173-175
58. Meyer B.J., Larkin T.A., Owen A., Astheimer L.B., Tapsell L.C., and Howe P.R.C. Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann Nutr Metab 48 (2004) 67-78
59. Holman R.T. Essential fatty acids in human nutrition. In: Bazán N.G., Brenner R.R., and Giusto M.N. (Eds). Function and biosynthesis of lipids (1977), Plenum Press, New York-London 515-534
60. Taylor A.J., Jennings P.E., Barnett A.H., Pandov H.I., and Lawson N. An alternative explanation for the change in erytrocyte fatty acids observed in diabetes mellitus. Clin Chem 33 11 (1987) 2083-2085
61. Vessby B., Gustafsson I.B., Tengblad S., Boberg M., and Andersson A. Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci 967 (2002) 183-195
62. Clifton P.M., and Nestel P.J. Relationship between plasma insulin and erytrocyte fatty acid composition. Prostaglandins Leukot Essent Fatty Acids 59 3 (1998) 191-194
63. Siscovick D.S., Raghunathan T.E., King I., Weinmann S., Wicklund K.G., Albright J., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274 (1995) 1363-1367